Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
For information on Biotech 2013-Life Sciences: Capturing Value and other Burrill & Company publications, click here.
Burrill & Company - 25 Years of Annual Reports on the Biotech Industry
For the past 25 years, Burrill & Company’s annual biotechnology industry reports have been considered required reading by top executives in the life sciences. The books are an invaluable, one-stop resource for making sense of the changing landscape in which the industry operates. Now, Burrill & Company is pleased to make available the entire series of reports—the first 25 years—in PDF format on a single DVD.
Since the early days of the biotechnology revolution, the industry has faced numerous challenges as it has grown. This collection of reports chronicles the growth and development of the industry as it happened.
Included in this DVD is “Biotech 2011-Life Sciences: Looking Back to See Ahead,” Burrill & Company's 25th annual report on the biotech industry, which addresses:
• How pharmaceutical companies are reinventing themselves to address their pipeline problems and the competition from generics
• New strategies investors are pursuing to improve their returns
• How the convergence of wireless, mobile, and Internet technologies is making personalized medicine a reality
• The global interplay between science, business, regulatory, reimbursement, politics, and policy
Comprehensive, unparalleled coverage of key trends makes “Looking Back to See Ahead” a critical resource for senior executives, as well as business development, sales, investment, legal, economic development, and other professionals who support the industry and compete in a fast-moving world.
G. Steven Burrill has been involved in the growth and prosperity of the biotechnology industry for more than 45 years. In 2002, Mr. Burrill was recognized as a biotech investment visionary by Scientific American magazine, and in 2008 he received the BayBio Pantheon DiNA lifetime achievement award for his worldwide biotech leadership. He is an advisor to University of Illinois Institute for Genomic Biology, University of Wisconsin College of Agricultural and Life Sciences, University of California, Davis, University of Minnesota College of Biological Sciences, and the Duke University Institute for Genome Science and Policy, and is an adjunct professor at University of California, San Francisco. He is the founder and CEO of Burrill & Company, a global financial services firm exclusively serving the life sciences industry.
Click here to view the table of contents and a list of charts and graphs contained in “Biotech 2011-Life Sciences: Looking Back to See Ahead."
Please note that we will only refund orders returned in their original packaging within three weeks of the order.
Add to cart$495.00